Прочитайте цю статтю вголос
Увімкніть мікрофон і читайте у своєму темпі. Слова підсвічуються на ходу, і ніхто не зупиняє вас через одну помилку.
Ваш звук не потрапляє до MovaReader: розпізнає його ваш браузер. Політикою конфіденційності
Увійдіть, щоб ця сесія збереглася в історії читання.
Biological Vector Control: Evaluating Public Health Field Trials in Yogyakarta
The burden of dengue fever has expanded dramatically across tropical urban environments over the past four decades. In response to the limitations of chemical insecticides, public health researchers have pioneered biological vector interventions. Among these, the release of mosquitoes infected with Wolbachia pipientis, an obligate intracellular bacterium, represents a paradigm shift. Although the microorganism occurs naturally in roughly half of all insect species, it does not naturally infect Aedes aegypti, the primary vector responsible for dengue, Zika, and chikungunya. Introducing this endosymbiont halts viral replication within the insect host. Consequently, such biological modifications prevent mosquitoes from transmitting pathogens to humans.
The underlying mechanism relies on a reproductive phenomenon known as cytoplasmic incompatibility. When uninfected females mate with infected males, the resulting eggs fail to hatch, whereas infected females reproduce successfully regardless of their mate's status.